ISMG Editors: The Battle Over Access to Frontier AI Models
Also: Washington's AI Policy Divide, FDA's Push for AI-Driven Clinical Trials
In this week's panel, four ISMG editors discussed the battle over who gets to access powerful AI cybersecurity models, policy issues unfolding in Washington over AI-driven cyber defenses, and how the FDA is beginning to test AI-supported real-time clinical trials to speed up drug development.
In this week's panel, four ISMG editors discussed the battle over who gets to access powerful AI cybersecurity models, policy issues unfolding in Washington over AI-driven cyber defenses, and how the FDA is beginning to test AI-supported real-time clinical trials to speed up drug development.